Why Amphastar Pharmaceuticals (AMPH) Is Up 8.4% After Strong Q3 Revenue and Key FDA Approvals [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
of US$17.35 million, with sales of Baqsimi and Primatene Mist contributing to performance and recent pipeline and product expansion announced. Despite a dip in profits from the previous year, the company secured key FDA product approvals, entered new licensing agreements, and saw continued growth in its two primary products, indicating active efforts to strengthen future business prospects. We'll examine how robust Baqsimi and Primatene Mist growth and recent product launches influence Amphastar's evolving investment narrative. We've found 16 US stocks that are forecast to pay a dividend yield of over 6% next year . See the full list for free. Amphastar Pharmaceuticals Investment Narrative Recap To be a shareholder in Amphastar Pharmaceuticals, you need to believe the company can continue to drive growth through its core products, like Baqsimi and Primatene Mist, while successfully expanding its pipeline and manufacturing capacity to offset competition and pricing pressure.
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? [Yahoo! Finance]Yahoo! Finance
- A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (NASDAQ:AMPH) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 11/6/25 - Beat
AMPH
Sec Filings
- 11/28/25 - Form 144
- 11/25/25 - Form 4
- 11/25/25 - Form 144
- AMPH's page on the SEC website